LU86718A1 - Nouveau facteur pour la regulation de la croissance cellulaire - Google Patents

Nouveau facteur pour la regulation de la croissance cellulaire Download PDF

Info

Publication number
LU86718A1
LU86718A1 LU86718A LU86718A LU86718A1 LU 86718 A1 LU86718 A1 LU 86718A1 LU 86718 A LU86718 A LU 86718A LU 86718 A LU86718 A LU 86718A LU 86718 A1 LU86718 A1 LU 86718A1
Authority
LU
Luxembourg
Prior art keywords
cells
polypeptide
amino acid
proliferation
oncostatin
Prior art date
Application number
LU86718A
Other languages
English (en)
French (fr)
Inventor
Mohammed Shoyab
Joyce M Zarling
Hans Marquardt
Marcia B Hanson
Mario N Lioubin
Thomas Joseph Brown
Original Assignee
Oncogen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen filed Critical Oncogen
Publication of LU86718A1 publication Critical patent/LU86718A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
LU86718A 1985-12-20 1986-12-17 Nouveau facteur pour la regulation de la croissance cellulaire LU86718A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US81123585A 1985-12-20 1985-12-20
US81123585 1985-12-20
US93528386A 1986-11-26 1986-11-26
US93528386 1986-11-26

Publications (1)

Publication Number Publication Date
LU86718A1 true LU86718A1 (fr) 1988-07-14

Family

ID=27123452

Family Applications (1)

Application Number Title Priority Date Filing Date
LU86718A LU86718A1 (fr) 1985-12-20 1986-12-17 Nouveau facteur pour la regulation de la croissance cellulaire

Country Status (29)

Country Link
JP (1) JP2559035B2 (de)
KR (1) KR920005920B1 (de)
CN (1) CN1017626B (de)
AT (1) AT400444B (de)
AU (2) AU601168B2 (de)
BE (1) BE905957A (de)
CA (1) CA1340296C (de)
CH (1) CH675727A5 (de)
CY (1) CY1608A (de)
DE (2) DE3645095C2 (de)
DK (1) DK174094B1 (de)
ES (1) ES2003180A6 (de)
FI (1) FI91484C (de)
FR (1) FR2597108B1 (de)
GB (1) GB2185485B (de)
GR (1) GR862936B (de)
HK (1) HK65691A (de)
HU (1) HU210694B (de)
IE (1) IE59415B1 (de)
IL (1) IL81017A (de)
IT (1) IT1213428B (de)
LU (1) LU86718A1 (de)
NL (1) NL8603209A (de)
NO (1) NO174556C (de)
NZ (1) NZ218634A (de)
OA (1) OA08494A (de)
PT (1) PT83986B (de)
SE (1) SE505059C2 (de)
SG (1) SG60891G (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4645828A (en) * 1984-03-23 1987-02-24 Oncogen Platelet related growth regulator
NZ218634A (en) * 1985-12-20 1991-06-25 Oncogen Peptide identified by its cross reactivity with a cell growth factor, dna, antibodies to peptide and test kits
US5681930A (en) * 1985-12-20 1997-10-28 Bristol-Myers Squibb Company Anti-oncostatin M monoclonal antibodies
NZ226799A (en) * 1987-11-06 1991-08-27 Oncogen Breast cancer inhibitory factor and method for inhibiting proliferation of neoplastic cells and compositions therefor
IL97622A (en) * 1990-03-29 1997-06-10 Oncogen Limited Partnership Se Monoclonal antibodies that inhibit growth of kaposi's sarcoma
IL97623A (en) * 1990-03-29 1996-01-19 Bristol Myers Squibb Co Monoclonal antibodies against oncostatin M, their preparation and pharmaceutical preparations containing them
WO1992002556A1 (en) * 1990-08-02 1992-02-20 Michael Valentine Agrez Human colon cancer cell-derived fibroblast elongation factor
CZ195193A3 (en) * 1992-09-25 1994-04-13 Lilly Co Eli Modified factor-4 of blood platelets, process of its preparation and pharmaceutical preparation in which it is comprised

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132776A (en) * 1978-02-15 1979-01-02 University Patents, Inc. Delivery of immunologically active components of transfer factor
US4645828A (en) * 1984-03-23 1987-02-24 Oncogen Platelet related growth regulator
NZ218634A (en) * 1985-12-20 1991-06-25 Oncogen Peptide identified by its cross reactivity with a cell growth factor, dna, antibodies to peptide and test kits

Also Published As

Publication number Publication date
FR2597108A1 (fr) 1987-10-16
FR2597108B1 (fr) 1991-02-15
CH675727A5 (de) 1990-10-31
GR862936B (en) 1987-10-28
AT400444B (de) 1995-12-27
DE3645095C2 (de) 1993-11-18
DE3643428A1 (de) 1987-09-24
SE8605459L (sv) 1987-06-21
IL81017A0 (en) 1987-03-31
CN1017626B (zh) 1992-07-29
DK174094B1 (da) 2002-06-10
CA1340296C (en) 1998-12-29
FI865156A (fi) 1987-06-21
FI865156A0 (fi) 1986-12-17
DK615386A (da) 1987-06-21
NL8603209A (nl) 1987-07-16
AU639048B2 (en) 1993-07-15
HU210694B (en) 1995-06-28
NZ218634A (en) 1991-06-25
GB8629997D0 (en) 1987-01-28
ATA340686A (de) 1995-05-15
PT83986A (en) 1987-01-01
CY1608A (en) 1992-04-03
JPS62236498A (ja) 1987-10-16
IL81017A (en) 1993-01-14
DK615386D0 (da) 1986-12-18
SE505059C2 (sv) 1997-06-16
IE863345L (en) 1987-06-20
GB2185485B (en) 1990-07-04
JP2559035B2 (ja) 1996-11-27
OA08494A (fr) 1988-07-29
FI91484C (fi) 1994-07-11
BE905957A (fr) 1987-06-17
SG60891G (en) 1991-08-23
KR870005645A (ko) 1987-07-06
NO174556B (no) 1994-02-14
SE8605459D0 (sv) 1986-12-18
IT8622787A0 (it) 1986-12-19
IT1213428B (it) 1989-12-20
PT83986B (pt) 1989-07-31
HK65691A (en) 1991-08-23
NO174556C (no) 1994-05-25
KR920005920B1 (ko) 1992-07-24
NO865178L (no) 1987-06-22
AU601168B2 (en) 1990-09-06
FI91484B (fi) 1994-03-31
IE59415B1 (en) 1994-02-23
AU6660886A (en) 1987-06-25
AU6776590A (en) 1991-03-14
CN86108955A (zh) 1987-12-02
ES2003180A6 (es) 1988-10-16
HUT43103A (en) 1987-09-28
GB2185485A (en) 1987-07-22
NO865178D0 (no) 1986-12-19
DE3643428C2 (de) 1990-08-23

Similar Documents

Publication Publication Date Title
Williams et al. Identification of a ligand for the c-kit proto-oncogene
JP3375949B2 (ja) 細胞障害性リンパ球成熟因子に対する抗体
RU2180850C2 (ru) Фармацевтическая композиция, содержащая c-kit-лиганд и гемопоэтический фактор, способ повышения уровней стволовых клеток в периферической крови, антагонист c-kit-лиганда, антисмысловая молекула нуклеиновой кислоты, способ увеличения уровней клеток периферической крови ex-vivo
JPS60252496A (ja) 新規なヒト生理活性ポリペプチド
JP2001157594A (ja) 上皮細胞に特異的な成長因子をコードするｄｎａ
WO2001075140A1 (en) HYBRID CYTOKINE OF IL-7 AND β-CHAIN OF HEPATOCYTE GROWTH FACTOR
JPH05503512A (ja) 白血球接着阻害因子としての［ａｌａ　ｉｌ―８］↓７↓７
EP0342219A1 (de) Zu menschlichem angiogenin homologes protein
LU86718A1 (fr) Nouveau facteur pour la regulation de la croissance cellulaire
Armstrong et al. Isolation and initial characterization of tumoricidal monokine (s) from the human monocytic leukemia cell line THP-1
EP0366532B1 (de) Glycosyliertes Interleukin-2 enthaltende Medikamente
CA2237495A1 (fr) Composes possedant des proprietes lectiniques, et leurs applications biologiques.
WO1999055863A1 (fr) Nouveau polypeptide, adnc le codant et son utilisation
EP0686194B1 (de) Wachtumsfaktor aus der harp-reihe, verfahren zu ihrer herstellung und verwendungen davon
EP0303538B1 (de) Von Monozyten abstammendes gefässwirksames Protein und dessen Analogen, Verfahren zu seiner Gewinnung und ihre Verwendungen für therapeutische Zwecke und zur Antikörperherstellung
EP0139555B1 (de) Synthetische Peptide, Verfahren zu deren Herstellung und sie enthaltende Arzneimittel
KR20010033640A (ko) 신규 폴리펩티드, 그 폴리펩티드를 암호하는 ｃＤＮＡ 및그 용도
JPS6229981A (ja) サルコフア−ガ・レクチンの構造遺伝子
CA2106193A1 (fr) Moyens pour le diagnostic in vitro de constituants de granules cytoplasmiques et applications biologiques
JPH08198899A (ja) 新規なポリペプチド、その製造方法、そのポリペプチドをコードするｄｎａ、そのｄｎａからなるベクター、そのベクターで形質転換された宿主細胞、そのポリペプチドの抗体、およびそのペプチドまたは抗体を含有する薬学的組成物
IL130224A (en) CELL GROWTH AND DIFFERENTIATION REGULATORY AChE PEPTIDE AND USES THEREOF
FR2638969A1 (fr) Procede d'isolement d'interleukine-2